Ultra-processed foods are everywhere in the American diet, and researchers are finding alarming consequences. Using national health data, scientists found that adults with the highest intake of these foods had a 47% higher risk of heart attack or stroke. The results held even after accounting for age, smoking, and income. Experts say reducing ultra-processed foods could become as important to publ
Realfood.gov now features a chatbot tool that’s Elon Musk-affiliated — and rather skeptical of some MAHA initiatives.
A Christian group announced a potentially landmark legal settlement that the ACLU says could establish new federal protections for harm reduction services.
The National Institutes of Health halted a treatment arm of Bayer and Johnson & Johnson’s Xarelto in a phase 3 stroke prevention trial after an independent committee flagged safety concerns and a lack of efficacy.
Late Tuesday, Fujifilm Biotechnologies opened the doors to its expanded United Kingdom site in Teesside, capping off a 400 million pound (around $546 million) project that’s been in the works since late 2021. With the debut, Fujifilm says it now boasts the largest single-use biopharmaceutical CDMO facility in the U.K.
PharmaEssentia will spend $46 million to build a manufacturing facility in Puerto Rico. The move forms part of the Taiwanese biotech’s global expansion strategy to support demand for its rare blood disease treatment, Besremi.
A batch of untitled letters posted on the FDA’s database in recent days takes aim at what the agency has termed “false or misleading” drug ads from the likes of Novo Nordisk, argenx and Sobi.
With Incyte set to lose patent protection for its blood cancer standout, Jakafi, in late 2028, the company will have to rely more on its topical cream, Opzelura. In its fourth full year on the market, the company reported that sales for the topical JAK inhibitor reached $678 million, which was a 33% increase from 2024.
The agreement includes mRNA vaccine supply and a technology transfer that allows Mexico's Laboratorios Liomont to produce Moderna's 2025-2026 COVID vaccine.
After ending 2025 with a strong fourth quarter, AstraZeneca management has doubled down on its ambitious “$80 billion by 2030” revenue target, outlining a roadmap to have more than 25 blockbuster medicines by the end of the decade.
Scientists have uncovered a surprising way tumors turn the immune system to their advantage. Researchers at the University of Geneva found that neutrophils—normally frontline defenders against infection—can be reprogrammed inside tumors to fuel cancer growth instead. Once exposed to the tumor environment, these immune cells begin producing a molecule called CCL3 that actively promotes tumor progre
Human evolution has long been tied to growing brain size, and new research suggests prenatal hormones may have played a surprising role. By studying the relative lengths of index and ring fingers — a clue to oestrogen and testosterone exposure in the womb — researchers found that higher prenatal estrogen was linked to larger head size in newborn boys.
The statements largely echo existing practices, but come as political pressure on transgender care grows.
The National Cancer Institute is studying ivermectin as a potential cancer treatment, according to its top official, alarming career scientists.
Abridge CTO Zach Lipton talks about how he sees the market for AI scribes evolving.
Autism has long been thought of as a condition that mostly affects boys, but a massive study from Sweden suggests that idea may be misleading. Tracking nearly 3 million people over decades, researchers found that while boys are diagnosed more often in childhood, girls steadily catch up during their teenage years. By early adulthood, autism diagnoses among males and females are nearly equal.
A large U.S. study suggests that not getting enough lycopene—the antioxidant that gives tomatoes their red color—may seriously raise the risk of severe gum disease in older adults. Researchers found that seniors with adequate lycopene intake had about one-third the risk of severe periodontitis compared with those who fell short.
A sweeping new review of ADHD treatments—drawing on more than 200 meta-analyses—cuts through years of mixed messaging and hype. To make sense of it all, researchers have launched an interactive, public website that lets people with ADHD and clinicians explore what actually works, helping them make clearer, evidence-based decisions—while also highlighting a major gap: most solid evidence only cover
Researchers at the University of Michigan have created an AI system that can interpret brain MRI scans in just seconds, accurately identifying a wide range of neurological conditions and determining which cases need urgent care. Trained on hundreds of thousands of real-world scans along with patient histories, the model achieved accuracy as high as 97.5% and outperformed other advanced AI tools.
FDA inspectors found a live spider and dead cricket in a facility that was compounding weight loss drugs for Hims & Hers.